The Use of Sedative Agents in Critically Ill Patients

作者: A. M. Burns , M. P. Shelly , G. R. Park

DOI: 10.2165/00003495-199243040-00007

关键词:

摘要: The main aim of sedation in the critically ill patient is to provide relief from anxiety and pain. current, ideal level should leave a who lightly asleep but easily roused. No single regimen suitable for all patients. be monitored, choice agent, dose route administration adjusted appropriately. Midazolam often used sleep anxiolysis. Alternatives include propofol isoflurane. Propofol titrated achieve desired sedation, its effects rapidly end when infusion stopped. Isoflurane also appears promising, special equipment needed administration. Morphine standard analgesic agent. principal metabolites, morphine-6-glucuronide, potent opioid agonist may accumulate renal failure. Of newer agents, alfentanil an agent infusion, Neuromuscular blocking agents are indicated only specific circumstances, once it known patients pain free. actions these unpredictable patient. Alterations drug effect elimination occur, especially with hepatic This apply active metabolites parent drug. When planning regimens, needs staffing levels must remembered. Attention environment important. morphine given by intermittent bolus or mainstay most regimens. short periods care on ICU, during weaning longer acting being eliminated.

参考文章(51)
Roberts P, Quinn K, Shelly Mp, Park Gr, Dihydrocodeine--a reversible cause of renal failure? European Journal of Anaesthesiology. ,vol. 6, pp. 303- 314 ,(1989)
M. A. Sultan, G. R. Park, M. P. Shelly, A. Bodenham, Midazolam infusions in critically ill patients. European Journal of Anaesthesiology. ,vol. 8, pp. 21- 27 ,(1991)
Marinella Mandelli, Gianni Tognoni, Silvio Garattini, Clinical pharmacokinetics of diazepam. Clinical Pharmacokinectics. ,vol. 3, pp. 72- 91 ,(1978) , 10.2165/00003088-197803010-00005
David M. Clive, Jeffrey S. Stoff, Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs New England Journal of Medicine. ,vol. 310, pp. 563- 572 ,(1984) , 10.1056/NEJM198403013100905
AlanR. Aitkenhead, SheilaM. Willatts, GilbertR. Park, CharlesH. Collins, IainMca. Ledingham, MichaelL. Pepperman, P. David Coates, AndrewR. Bodenham, MarkB. Smith, PeterG.M. Wallace, COMPARISON OF PROPOFOL AND MIDAZOLAM FOR SEDATION IN CRITICALLY ILL PATIENTS The Lancet. ,vol. 334, pp. 704- 709 ,(1989) , 10.1016/S0140-6736(89)90770-8
K Adam, I Oswald, Sleep helps healing. BMJ. ,vol. 289, pp. 1400- 1401 ,(1984) , 10.1136/BMJ.289.6456.1400
C. Ferrier, J. Marty, Y. Bouffard, J. P. Haberer, J. C. Levron, P. Duvaldestin, Alfentanil pharmacokinetics in patients with cirrhosis. Anesthesiology. ,vol. 62, pp. 480- 484 ,(1985) , 10.1097/00000542-198504000-00018
KYOICHI SHIMOMURA, OSAMU KAMATA, SHOWA UEKI, SEIU IDA, KAZUTA OGURI, HIDETOSHI YOSHIMURA, HISAO TSUKAMOTO, Analgesic Effect of Morphine Glucuronides Tohoku Journal of Experimental Medicine. ,vol. 105, pp. 45- 52 ,(1971) , 10.1620/TJEM.105.45
H.J. McQuay, R.E.S. Bullingham, R.A. Moore, D. Phil, Acute opiate tolerance in man. Life Sciences. ,vol. 28, pp. 2513- 2517 ,(1981) , 10.1016/0024-3205(81)90593-2
Richard I. Mazze, Michael J. Cousins, Gary A. Barr, Renal effects and metabolism of isoflurane in man. Anesthesiology. ,vol. 40, pp. 536- 542 ,(1974) , 10.1097/00000542-197406000-00006